Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 1, Pages 46
Publisher
MDPI AG
Online
2021-12-27
DOI
10.3390/biomedicines10010046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease diagnosed by transient elastography and liver biopsy
- (2021) I. Mikolasevic et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
- (2021) Marcello Dallio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol – PKCε – insulin receptorT1160 phosphorylation
- (2021) Kun Lyu et al. JCI Insight
- Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
- (2021) Paola Dongiovanni et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates Nonalcoholic Steatohepatitis through Innate and Adaptive Signaling
- (2021) Fanta Barrow et al. HEPATOLOGY
- Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice
- (2021) Dániel Kucsera et al. Frontiers in Physiology
- Extracellular Vesicles as Inflammatory Drivers in NAFLD
- (2021) Akshatha N. Srinivas et al. Frontiers in Immunology
- Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study
- (2021) Emanuel Fryk et al. EBioMedicine
- Role of Insulin Resistance in MAFLD
- (2021) Yoshitaka Sakurai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone Deacetylase 1 Reduces Lipogenesis by Suppressing SREBP1 Transcription in Human Sebocyte Cell Line SZ95
- (2021) Hye Sun Shin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?
- (2021) Johanna Heitmann et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis
- (2021) Kunimaro Furuta et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
- (2021) Alessandro Federico et al. Nutrients
- Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
- (2021) Oriol Juanola et al. International Journal of Environmental Research and Public Health
- The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
- (2021) Rosa Martín-Mateos et al. Frontiers in Immunology
- Systematic review with network meta‐analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH
- (2021) Abdul M. Majzoub et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases
- (2021) Chang Liu et al. FASEB JOURNAL
- TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
- (2021) Rohit Loomba et al. GASTROENTEROLOGY
- Unwrapping the mechanisms of ceramide and fatty acid-initiated signals leading to immune-inflammatory responses in obesity
- (2021) Salih Kucuk et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
- (2021) Nikolaos Perakakis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
- (2021) Stephen A. Harrison et al. NATURE MEDICINE
- Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
- (2021) V. Ratziu et al. NATURE MEDICINE
- ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
- (2021) Roberto A. Calle et al. NATURE MEDICINE
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
- (2021) Lucía Lavín-Alconero et al. Trials
- Effects of the dual sodium‐glucose linked transporter inhibitor, licogliflozin versus placebo or empagliflozin in patients with type 2 diabetes and heart failure
- (2020) Rudolf A. Boer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Non-alcoholic fatty liver disease in inflammatory bowel disease patients
- (2020) Katerina Karaivazoglou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease
- (2020) Eleonora Scorletti et al. GASTROENTEROLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway
- (2020) Charng-Cherng Chyau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of lipid‐induced macrophage polarization through modulating PPAR‐γ activity affects hepatic lipid metabolism via TLR4/NF‐κB signaling pathway
- (2020) Hui‐Min Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
- (2020) Federica Zatterale et al. Frontiers in Physiology
- Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability
- (2020) Laura Craven et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways
- (2020) Litao Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
- (2020) Ahmed Abdallah Salman et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lytic cell death in metabolic liver disease
- (2020) Jérémie Gautheron et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review
- (2020) Katarzyna Kolczynska et al. Lipids in Health and Disease
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Characterization of the immune cell landscape of patients with NAFLD
- (2020) Tom Diedrich et al. PLoS One
- A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
- (2020) Paula Iruzubieta et al. Journal of Clinical Medicine
- Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways
- (2020) Lamiaa A. Ahmed et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Blocking integrin α4β7-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis
- (2020) Ravi P. Rai et al. JOURNAL OF HEPATOLOGY
- Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
- (2020) Susanne Gaul et al. JOURNAL OF HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease
- (2020) Ekta Pandey et al. Frontiers in Physiology
- Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity
- (2020) Laura Antonucci et al. Journal of Immunology Research
- Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
- (2020) Haiou Li et al. Frontiers in Immunology
- A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
- (2020) Kun Lyu et al. Cell Metabolism
- Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver
- (2020) Anneleen Remmerie et al. IMMUNITY
- Effects of cotadutide on biomarkers of non-alcoholic steatohepatitis in overweight or obese subjects with type 2 diabetes mellitus: a 54-week analysis of a randomized phase 2b study
- (2020) Rajaa Nahra et al. JOURNAL OF HEPATOLOGY
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
- (2020) Patricia Rada et al. Cell Death & Disease
- Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
- (2020) Giljae Lee et al. Nature Communications
- Phage Therapy for Alcoholic Hepatitis
- (2020) Gina A. Suh HEPATOLOGY
- Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low‐grade inflammation via blockade of Kupffer cell M1 polarization
- (2020) Yue Yin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD
- (2020) Eduardo Vilar-Gomez et al. Journal of Clinical Lipidology
- Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
- (2020) Carmelo Luci et al. Frontiers in Endocrinology
- Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
- (2020) Tim Hendrikx et al. Frontiers in Endocrinology
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience
- (2020) Roberto Scicali et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
- (2019) Wan Mu et al. Frontiers in Pharmacology
- Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)
- (2019) Ryo Goto et al. FEBS Open Bio
- MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism
- (2019) Seok-Ho Kim et al. Scientific Reports
- Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease
- (2019) Tawfik Khoury et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- Fibroblast growth factors in control of lipid metabolism
- (2019) Dicky Struik et al. CURRENT OPINION IN LIPIDOLOGY
- The immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis
- (2019) Tianqi Wang et al. FASEB JOURNAL
- Novel MRI assessment of treatment response in HIV ‐associated NAFLD : a randomized trial of an SCD 1 inhibitor ( ARRIVE Trial)
- (2019) Veeral H. Ajmera et al. HEPATOLOGY
- Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Ashkan Afshin et al. LANCET
- Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes
- (2019) Andreea-Manuela Mirea et al. MOLECULAR MEDICINE
- Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
- (2019) Jessica R. Allegretti et al. Clinical Gastroenterology and Hepatology
- 140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects
- (2019) ALEX DEPAOLI et al. DIABETES
- Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
- (2019) Pieter de Groot et al. GUT
- Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis
- (2019) Shinya Tsurusaki et al. Cell Death & Disease
- Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
- (2019) Natalie Stiglund et al. Frontiers in Immunology
- Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
- (2019) Stefania Grimaudo et al. Clinical Gastroenterology and Hepatology
- Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
- (2019) M.S. Capehorn et al. DIABETES & METABOLISM
- Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation
- (2019) Fei Chen et al. HEPATOLOGY
- γδ T cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
- (2019) Alejandro Torres‐Hernandez et al. HEPATOLOGY
- NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
- (2019) Valerio Rosato et al. International Journal of Environmental Research and Public Health
- Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
- (2019) Ildiko Lingvay et al. Lancet Diabetes & Endocrinology
- The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype
- (2019) Antonia O. Cuff et al. Frontiers in Immunology
- MAIT cells in metabolic diseases
- (2019) Léo Bertrand et al. Molecular Metabolism
- Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism
- (2019) Jin Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin‐22 ameliorates neutrophil‐driven nonalcoholic steatohepatitis through multiple targets
- (2019) Seonghwan Hwang et al. HEPATOLOGY
- Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges
- (2019) Ziyi Song et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- (2019) Yi Duan et al. NATURE
- Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
- (2019) Jing Yuan et al. Cell Metabolism
- Hepatic NK cells attenuate fibrosis progression of non‐alcoholic steatohepatitis in dependent of CXCL10‐mediated recruitment
- (2019) Yuting Fan et al. LIVER INTERNATIONAL
- Mice lacking PKC-θ in skeletal muscle have reduced intramyocellular lipid accumulation and increased insulin responsiveness in skeletal muscle
- (2018) Bailey Peck et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- Animal models of NAFLD from a hepatologist's point of view
- (2018) Daniel Jahn et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
- (2018) Stefania Bruzzì et al. FREE RADICAL BIOLOGY AND MEDICINE
- Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation
- (2018) Samar H Ibrahim et al. GUT
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- Non-invasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial
- (2018) Helena W Rodbard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fructose metabolism and metabolic disease
- (2018) Sarah A. Hannou et al. JOURNAL OF CLINICAL INVESTIGATION
- A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
- (2018) Journal of Gastrointestinal and Liver Diseases
- Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD
- (2018) C. Caussy et al. JOURNAL OF HEPATOLOGY
- JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study
- (2018) A.M. Diehl et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Farnush Bakhshimoghaddam et al. JOURNAL OF NUTRITION
- Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
- (2018) Zobair M. Younossi LIVER TRANSPLANTATION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- The gut–liver axis and the intersection with the microbiome
- (2018) Anupriya Tripathi et al. Nature Reviews Gastroenterology & Hepatology
- Mucosal-Associated Invariant T Cells in Chronic Inflammatory Liver Disease
- (2018) Fabian Bolte et al. SEMINARS IN LIVER DISEASE
- Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
- (2018) Pushpa Hegde et al. Nature Communications
- Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
- (2018) Kumiko Shiba et al. Scientific Reports
- Dietary carbohydrates: role of quality and quantity in chronic disease
- (2018) David S Ludwig et al. BMJ-British Medical Journal
- Dietary carbohydrates: role of quality and quantity in chronic disease
- (2018) David S Ludwig et al. BMJ-British Medical Journal
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
- (2018) Junjiang Pan et al. CELLULAR IMMUNOLOGY
- Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
- (2018) S.R. Sharpton et al. Clinical Gastroenterology and Hepatology
- SGLT2 inhibitors and incretin agents: Associations with alanine aminotransferase activity in type 2 diabetes
- (2018) H.S. Bajaj et al. DIABETES & METABOLISM
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
- (2018) Naveed Sattar et al. DIABETOLOGIA
- Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
- (2018) Jingjing Cai et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
- (2018) Yuji Ogawa et al. Scientific Reports
- Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization
- (2018) Yanmei Li et al. Frontiers in Immunology
- ILC-poiesis: Ensuring tissue ILC differentiation at the right place and time
- (2018) Ai Ing Lim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Modulation of Insulin Resistance in NAFLD
- (2018) Reenam Khan et al. HEPATOLOGY
- STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis
- (2018) Yongsheng Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis
- (2018) Igor Maricic et al. JOURNAL OF IMMUNOLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- Metabolically healthy versus metabolically unhealthy obesity
- (2018) Carla Iacobini et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- (2018) Francesco Bifari et al. PHARMACOLOGICAL RESEARCH
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
- (2018) Jordan Rowlands et al. Frontiers in Endocrinology
- Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes
- (2017) Akio Ohta et al. EXPERT OPINION ON PHARMACOTHERAPY
- Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
- (2017) Cristina Alonso et al. GASTROENTEROLOGY
- Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice
- (2017) Mitchell Bijnen et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Hepatic nucleotide binding oligomerization domain- like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease
- (2017) Hironori Mitsuyoshi et al. HEPATOLOGY RESEARCH
- Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials
- (2017) Yuya Seko et al. JOURNAL OF GASTROENTEROLOGY
- Adapting to obesity with adipose tissue inflammation
- (2017) Shannon M. Reilly et al. Nature Reviews Endocrinology
- The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner
- (2017) Fenglei Li et al. Nature Communications
- Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
- (2017) Claire Duvallet et al. Nature Communications
- Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex
- (2017) So Yeon Kim et al. Nature Communications
- The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial
- (2017) Leila Javadi et al. Iranian Red Crescent Medical Journal
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
- (2017) Bo Ahrén et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
- (2017) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study
- (2017) Yaru Li et al. PLoS One
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors
- (2016) Takamasa Ohki et al. CLINICAL DRUG INVESTIGATION
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- Post-translational modifications of lipid-activated nuclear receptors: Focus on metabolism
- (2016) Natalia Becares Salles et al. ENDOCRINOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- NKp46+ natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice
- (2016) Annie-Carole Tosello-Trampont et al. HEPATOLOGY
- Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
- (2016) Catherine M. Viscoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ChREBP regulates fructose-induced glucose production independently of insulin signaling
- (2016) Mi-Sung Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
- (2016) Irma Garcia-Martinez et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells
- (2016) Feng Zhang et al. Journal of Digestive Diseases
- Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2
- (2016) Dewei Ye et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial
- (2016) Farzad Shidfar et al. Journal of Research in Medical Sciences
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
- (2016) Chi Ma et al. NATURE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durable coexistence of donor and recipient strains after fecal microbiota transplantation
- (2016) Simone S. Li et al. SCIENCE
- The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
- (2016) Mark A. Herman et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
- (2016) Naoto Kubota et al. Nature Communications
- Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
- (2016) Teruo Jojima et al. Diabetology & Metabolic Syndrome
- Phosphorylation of PPARγ at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4
- (2016) Yuxin Shu et al. Oncotarget
- ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch
- (2016) Steven Zhao et al. Cell Reports
- Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
- (2016) Nadja B. Kristensen et al. Genome Medicine
- The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
- (2016) Gabriele Forlani et al. Journal of Diabetes Research
- The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
- (2016) Yasushi Honda et al. PLoS One
- Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation
- (2016) D. T. Reid et al. PLoS One
- Myeloperoxidase–Hepatocyte–Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis
- (2015) Benjamin Pulli et al. ANTIOXIDANTS & REDOX SIGNALING
- Hepatocytes: a key cell type for innate immunity
- (2015) Zhou Zhou et al. Cellular & Molecular Immunology
- The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
- (2015) S. Rolla et al. CLINICAL SCIENCE
- Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2015) Stergios A. Polyzos et al. DIABETOLOGIA
- Association of body composition and eating behavior in the normal weight obese syndrome
- (2015) Laura Di Renzo et al. Eating and Weight Disorders-Studies on Anorexia Bulimia and Obesity
- Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease
- (2015) N. U. Ashraf et al. FREE RADICAL RESEARCH
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease
- (2015) Johannie du Plessis et al. GASTROENTEROLOGY
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
- (2015) Peng Chen et al. HEPATOLOGY
- Effect of Vildagliptin on Hepatic Steatosis
- (2015) Mavin Macauley et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Hepatocytes as Immunological Agents
- (2015) Ian N. Crispe JOURNAL OF IMMUNOLOGY
- Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
- (2015) Monika Rau et al. JOURNAL OF IMMUNOLOGY
- Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner
- (2015) Eiji Kakazu et al. JOURNAL OF LIPID RESEARCH
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2015) Su Jong Yu et al. MEDICINE
- The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
- (2015) María Teresa Arias-Loste et al. Biomed Research International
- Association between Complement C3 and Prevalence of Fatty Liver Disease in an Adult Population: A Cross-Sectional Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study
- (2015) Qiyu Jia et al. PLoS One
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- 3, 3′-diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance
- (2014) Yun Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Glucose Transporter 8 (GLUT8) Mediates Fructose-inducedde NovoLipogenesis and Macrosteatosis
- (2014) Brian J. DeBosch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
- (2014) Chris J. Weston et al. JOURNAL OF CLINICAL INVESTIGATION
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli
- (2014) Callie A. Norris et al. PLoS One
- A Small Amount of Dietary Carbohydrate Can Promote the HFD-Induced Insulin Resistance to a Maximal Level
- (2014) Shuang Mei et al. PLoS One
- Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
- (2014) Davide Povero et al. PLoS One
- IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet
- (2013) Xiao-Yu Luo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease
- (2013) Jinghong Wan et al. HEPATOLOGY
- IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
- (2013) Isaac T.W. Harley et al. HEPATOLOGY
- The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
- (2013) Victoria L. Gadd et al. HEPATOLOGY
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
- (2012) Christopher K. Glass et al. Cell Metabolism
- Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis
- (2012) Miroslaw Kornek et al. GASTROENTEROLOGY
- Sterile Inflammation in the Liver
- (2012) Paul Kubes et al. GASTROENTEROLOGY
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase
- (2012) Laura Gomez-Santos et al. HEPATOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis
- (2012) Nazarena E. Ferreyra Solari et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice
- (2012) Sander S. Rensen et al. PLoS One
- Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis
- (2011) CECILIA SÖDERBERG et al. APMIS
- Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
- (2011) Y. Tang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
- (2011) María Eugenia Inzaugarat et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver
- (2011) Renaud Dentin et al. JOURNAL OF HEPATOLOGY
- Increased production of sonic hedgehog by ballooned hepatocytes
- (2011) Fatima Rangwala et al. JOURNAL OF PATHOLOGY
- Intrahepatic natural killer T cell populations are increased in human hepatic steatosis
- (2011) Michael Adler WORLD JOURNAL OF GASTROENTEROLOGY
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
- (2010) Takuya Miyagi et al. JOURNAL OF GASTROENTEROLOGY
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roles of liver innate immune cells in nonalcoholic fatty liver disease
- (2010) Yu-Tao Zhan WORLD JOURNAL OF GASTROENTEROLOGY
- Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis
- (2009) Sander S. Rensen et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease
- (2009) Kazuto Tajiri et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis
- (2009) Michael Kremer et al. HEPATOLOGY
- Major histocompatibility complex class I-related chains A and B (MIC A/B): A novel role in nonalcoholic steatohepatitis
- (2009) Alisan Kahraman et al. HEPATOLOGY
- Activation of the complement system in human nonalcoholic fatty liver disease
- (2009) Sander S. Rensen et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
- (2009) Satoshi Nishimura et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search